ABB Ltd. (NYSE: ABB) was raised to Neutral from Sell at Goldman Sachs.

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) was last seen down almost 40% at $39.70 after announcing the termination of a Phase 3 trial due to a mortality imbalance. Jefferies maintained a Buy rating, but the firm slashed its target price to $58 from $86. JPMorgan downgraded it to Neutral from Overweight, and Barclays cut its rating to Equal Weight from Overweight.

BorgWarner Inc. (NYSE: BWA) was downgraded to Neutral from Buy at Goldman Sachs.

Callon Petroleum Co. (NYSE: CPE) was started as Neutral at Mizuho, and the firm set a $16 price target (versus a $15.67 close) in the call.

CBRE Group Inc. (NYSE: CBG) was started as Outperform with a $35 price target (versus a $27.52 close) at Wedbush Securities.

Colony Capital Inc. (NYSE: CLNY) was started as Outperform with a $26 price target (versus a $17.98 close) at Wedbush Securities. It also comes with an 8% or so dividend yield.

Honeywell International Inc. (NYSE: HON) was started as Outperform with a $135 price target at Robert W. Baird.

HSN Inc. (NASDAQ: HSNI) was downgraded to Neutral from Buy at Citigroup.

Immunomedics Inc. (NASDAQ: IMMU) was assumed as Buy at Jefferies, and the prior price target of $5 is now $5.50 (versus a $3.28 close). Jefferies even assigned a 55% probability of accelerated approval based on Phase 2 data in 2018.

New Residential Investment Corp. (NYSE: NRZ) was started as Outperform with a $17 price target (versus a $13.52 close) at Wedbush Securities. It comes with a double-digit 13% dividend yield.

Smith & Wesson Holding Corp. (NASDAQ: SWHC) was downgraded to Hold from Buy and the price target was cut to $29 from $36 at Wunderlich.

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was assumed as Buy at Jefferies, and the old price target of $15 is now $23 (versus a $16.25 close). Despite strong performance since the end of August, the firm cited multiple drivers for stronger gains ahead.

Merrill Lynch has 4 US 1 List picks with very solid dividends.

Wednesday’s top analyst calls were in Broadcom, Flextronics, Genworth Financial, Micron Technology, Salesforce.com, UBS, Wal-Mart and over a dozen more.